Coinhibitory receptor PD-1H preferentially suppresses CD4+ T cell-mediated immunity

Journal of Clinical Investigation

Volumn 124, Issue 5, 2014, Pages 1966-1975

  Flies, Dallas B ^a   Han, Xue ^a   Higuchi, Tomoe ^a   Zheng, Linghua ^a   Sun, Jingwei ^a   Ye, Jessica Jane ^a   Chen, Lieping ^a  

^a YALE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 HOMOLOG PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE EXACERBATION; EXPERIMENTAL HEPATITIS; GLIOMA; HEMATOPOIETIC CELL; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STIMULATION; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ACUTE DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGEN PRESENTATION; B7 ANTIGENS; BRAIN NEOPLASMS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GLIOMA; HEPATITIS; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT;

EID: 84899722578     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI74589     Document Type: Article

References (20)

1. Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13(4):227-242.
2. Baitsch L, et al. Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization. PLoS One. 2012;7(2):e30852.
3. Riha P, Rudd CE. CD28 co-signaling in the adaptive immune response. Self Nonself. 2010;1(3):231-240.
4. Zhu Y, Yao S, Chen L. Cell surface signaling molecules in the control of immune responses: a tide model. Immunity. 2011;34(4):466-478.
5. Yao S, Zhu Y, Chen L. Advances in targeting cell surface signalling molecules for immune modulation. Nat Rev Drug Discov. 2013;12(2):130-146.
6. Linsley PS, Nadler SG. The clinical utility of inhibiting CD28-mediated costimulation. Immunol Rev. 2009;229(1):307-321.
7. Ott PA, Hodi FS, Robert C. CTLA-4 and PD-1/ PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients. Clin Cancer Res. 2013;19(19):5300-5309.
8. Brahmer JR, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366(26):2455-2465.
9. Topalian SL, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443-2454.
10. Flies DB, Wang S, Xu H, Chen L. Cutting edge: a monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models. J Immunol. 2011;187(4):1537-1541.
11. Wang L, et al. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. J Exp Med. 2011;208(3):577-592.
12. Tang T, et al. A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol. 2010;28(7):749-755.
13. Cao Q, Batey R, Pang G, Russell A, Clancy R. IL-6, IFN- and TNF- production by liver-associated T cells and acute liver injury in rats administered concanavalin A. Immunol Cell Biol. 1998; 76(6):542-549.
14. Dennert G, Aswad F. The role of NKT cells in animal models of autoimmune hepatitis. Crit Rev Immunol. 2006;26(5):453-473.
15. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 1992;90(1):196-203.
16. Durante M, Reppingen N, Held KD. Immunologically augmented cancer treatment using modern radiotherapy. Trends Mol Med. 2013;19(9):565-582.
17. Liu SZ. Cancer control related to stimulation of immunity by low-dose radiation. Dose Response. 2007;5(1):39-47.
18. Moravan MJ, Olschowka JA, Williams JP, O'Banion MK. Cranial irradiation leads to acute and persistent neuroinflammation with delayed increases in T-cell infiltration and CD11c expression in C57BL/6 mouse brain. Radiat Res. 2011;176(4):459-473.
19. Newcomb EW, et al. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. Clin Cancer Res. 2006;12(15):4730-4737.
20. Maes W, Van Gool SW. Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model. Cancer Immunol Immunother. 2011;60(2):153-160.